Priority Date: 08.06.12 (US 201261657423P)

FBXO3 INHIBITORS

  • Application ID: EP13800256
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna hgf ltd
operating since 1995
1179.38
Headquarter in Leeds and 13 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 191 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 08.06.2012 - Priority Date (US 201261657423P)
  • 12.12.2013 - Publication A1 (WO2013184202)
  • 15.04.2015 - Publication A1 (EP2858975)